XML 112 R90.htm IDEA: XBRL DOCUMENT v3.20.2
Business Segment Information - Business Segment Information (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Oct. 31, 2020
Jul. 31, 2020
Apr. 30, 2020
Jan. 31, 2020
Oct. 31, 2019
Jul. 31, 2019
Apr. 30, 2019
Jan. 31, 2019
Oct. 31, 2020
Oct. 31, 2019
Oct. 31, 2018
Segment Reporting Information [Line Items]                      
Net sales $ 681.6 $ 578.2 $ 524.9 $ 646.2 $ 691.6 $ 679.4 $ 654.3 $ 628.1 $ 2,430.9 $ 2,653.4 $ 2,532.8
Operating income (loss)                 311.8 546.7 403.1
Interest expense                 36.8 68.0 82.7
Other expense (income), net                 8.5 1.3 (11.5)
Income before income taxes                 266.5 477.4 331.9
Identifiable assets 6,737.5       6,274.5       6,737.5 6,274.5 6,112.8
Depreciation expense                 149.9 135.0 128.4
Amortization expense                 137.2 145.8 146.7
Capital expenditures                 310.4 292.1 193.6
CooperVision                      
Segment Reporting Information [Line Items]                      
Net sales                 1,843.0 1,972.9 1,882.0
CooperSurgical                      
Segment Reporting Information [Line Items]                      
Net sales                 587.9 680.5 650.8
Corporate                      
Segment Reporting Information [Line Items]                      
Net sales                 0.0 0.0 0.0
Operating income (loss)                 (49.2) (47.6) (56.8)
Identifiable assets 207.4       173.1       207.4 173.1 165.1
Depreciation expense                 0.0 0.2 0.2
Amortization expense                 0.0 0.0 0.0
Capital expenditures                 0.0 0.0 0.1
Operating Segments | CooperVision                      
Segment Reporting Information [Line Items]                      
Net sales                 1,843.0 1,972.9 1,882.0
Operating income (loss)                 375.7 506.4 479.8
Identifiable assets 4,236.3       3,911.6       4,236.3 3,911.6 3,746.0
Depreciation expense                 138.2 125.8 120.1
Amortization expense                 32.4 40.9 43.6
Capital expenditures                 260.3 259.0 178.4
Operating Segments | CooperSurgical                      
Segment Reporting Information [Line Items]                      
Net sales                 587.9 680.5 650.8
Operating income (loss)                 (14.7) 87.9 (19.9)
Identifiable assets $ 2,293.8       $ 2,189.8       2,293.8 2,189.8 2,201.7
Depreciation expense                 11.7 9.0 8.1
Amortization expense                 104.8 104.9 103.1
Capital expenditures                 $ 50.1 $ 33.1 $ 15.1